ME01713B - Treatment of symptoms of parkinson's disease with non-imidazole alkylamines histamine h3-receptor ligands - Google Patents

Treatment of symptoms of parkinson's disease with non-imidazole alkylamines histamine h3-receptor ligands

Info

Publication number: ME01713B
Authority: ME; Montenegro
Prior art keywords: parkinson; symptoms; disease; treatment; receptor ligands
Prior art date: 2005-04-01

Application number

MEP-2013-98A

Other languages

Unknown language (me)

Inventor

Jean-Charles Schwartz

Jeanne-Marie Lecomte

Original Assignee

Bioprojet Soc Civ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-01

Filing date

2006-03-30

Publication date

2014-09-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35169680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01713(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-03-30 Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ

2014-09-20 Publication of ME01713B publication Critical patent/ME01713B/en

Links

RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 2
102000004384 Histamine H3 receptors Human genes 0.000 title 1
108090000981 Histamine H3 receptors Proteins 0.000 title 1
208000018737 Parkinson disease Diseases 0.000 title 1
-1 imidazole alkylamines Chemical class 0.000 title 1
239000003446 ligand Substances 0.000 title 1
208000024891 symptom Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MEP-2013-98A 2005-04-01 2006-03-30 Treatment of symptoms of parkinson's disease with non-imidazole alkylamines histamine h3-receptor ligands ME01713B (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP05290727A EP1707203A1 (en)	2005-04-01	2005-04-01	Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
US66861805P	2005-04-06	2005-04-06
PCT/IB2006/000739 WO2006103546A2 (en)	2005-04-01	2006-03-30	Treatment of parkinson's disease, obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3-receptor ligands
EP06744466.1A EP1863487B2 (en)	2005-04-01	2006-03-30	Treatment of symptoms of parkinson's disease with non-imidazole alkylamines histamine h3-receptor ligands

Publications (1)

Publication Number	Publication Date
ME01713B true ME01713B (en)	2014-09-20

Family

ID=35169680

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-2013-98A ME01713B (en)	2005-04-01	2006-03-30	Treatment of symptoms of parkinson's disease with non-imidazole alkylamines histamine h3-receptor ligands

Country Status (27)

Country	Link
US (1)	US8486947B2 (en)
EP (2)	EP1707203A1 (en)
JP (3)	JP5546761B2 (en)
KR (1)	KR101308527B1 (en)
CN (1)	CN101171009B (en)
AU (1)	AU2006228413C1 (en)
BR (1)	BRPI0612216B1 (en)
CA (1)	CA2603656C (en)
CY (1)	CY1114636T1 (en)
DK (1)	DK1863487T4 (en)
EA (1)	EA016007B1 (en)
ES (1)	ES2426008T5 (en)
HR (1)	HRP20130748T4 (en)
MA (1)	MA29353B1 (en)
ME (1)	ME01713B (en)
MX (1)	MX2007012162A (en)
NO (1)	NO343603B1 (en)
NZ (1)	NZ561940A (en)
PL (1)	PL1863487T5 (en)
PT (1)	PT1863487E (en)
RS (1)	RS52911B2 (en)
SG (1)	SG147415A1 (en)
SI (1)	SI1863487T2 (en)
TN (1)	TNSN07365A1 (en)
UA (1)	UA94902C2 (en)
WO (1)	WO2006103546A2 (en)
ZA (1)	ZA200708086B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9108948B2 (en)	2006-06-23	2015-08-18	Abbvie Inc.	Cyclopropyl amine derivatives
BRPI0712823A2 (en)	2006-06-23	2012-07-24	Abbott Lab	cyclopropyl amine derivatives as h3 histamine receptor modulators
FR2903904A1 (en) *	2006-07-21	2008-01-25	Bioprojet Soc Civ Ile	ASSOCIATION OF MODAFINIL AND AN ANTAGONIST OR REVERSE H3 RECEPTOR AGONIST
HRP20130044T1 (en)	2006-07-25	2013-02-28	Cephalon, Inc.	Pyridizinone derivatives
US8153813B2 (en)	2007-12-20	2012-04-10	Abbott Laboratories	Benzothiazole and benzooxazole derivatives and methods of use
EP2250176B1 (en)	2008-01-30	2012-08-01	Cephalon, Inc.	Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
FR2932479A1 (en) *	2008-06-13	2009-12-18	Servier Lab	NOVEL AZABICYCLIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US9186353B2 (en)	2009-04-27	2015-11-17	Abbvie Inc.	Treatment of osteoarthritis pain
WO2012037258A1 (en)	2010-09-16	2012-03-22	Abbott Laboratories	Processes for preparing 1,2-substituted cyclopropyl derivatives
US9181275B2 (en)	2011-08-11	2015-11-10	Abbvie Inc.	Mercaptoamidine derivatives and methods of use
WO2013151982A1 (en)	2012-04-03	2013-10-10	Arena Pharmaceuticals, Inc.	Methods and compounds useful in treating pruritus, and methods for identifying such compounds
NZ705813A (en) *	2012-10-05	2018-02-23	Vtv Therapeutics Llc	Treatment of mild and moderate alzheimer’s disease
EP3391886A1 (en)	2017-04-19	2018-10-24	Novartis AG	The use of a h3r inverse agonist for the treatment of shift work disorder
US20200282215A1 (en)	2019-03-06	2020-09-10	Medtronic Xomed, LLC	Evaluating stimulation eficacy for treating sleep apnea and lingual muscle tone sensing system for improved osa therapy
EP4248969A1 (en)	2022-03-23	2023-09-27	Bioprojet	Use of pitolisant for treating severe fatigue
EP4688166A1 (en)	2023-03-31	2026-02-11	BIOPROJET Pharma	Polymorph form of pitolisant hydrochloride
WO2025082974A1 (en)	2023-10-16	2025-04-24	Bioprojet Pharma	New formulations of pitolisant and methods of use

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5815945A (en) *	1981-07-21	1983-01-29	Teikoku Hormone Mfg Co Ltd	Novel phenoxyalkylamine derivative
FR2579596B1 (en)	1985-03-26	1987-11-20	Inst Nat Sante Rech Med	(IMIDAZOLYL-4) PIPERIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2671083B1 (en)	1990-12-31	1994-12-23	Inst Nat Sante Rech Med	NEWS 4- (4-IMIDAZOLYL) PIPERIDINES SUBSTITUTED IN 1, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS.
JPH06505265A (en)	1991-02-27	1994-06-16	シード・キャピタル・インベストメント・（エス・シー・アイ）・ベスローテン・フェンノートシャップ	Imidazole derivatives having agonistic or antagonistic activity on histamine H↓3 receptors
US5463074A (en)	1991-12-18	1995-10-31	Schering Corporation	Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
DE69212164T2 (en)	1991-12-18	1996-12-05	Schering Corp., Kenilworth, N.J.	IMIDOLYLALKYL DERIVATIVES SUBSTITUTED WITH A NITROGEN-CONTAINING 6-PIECE RING
FR2686084B1 (en)	1992-01-10	1995-12-22	Bioprojet Soc Civ	NEW IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS.
US5380858A (en)	1992-04-01	1995-01-10	The University Of Toledo	Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists
US5639775A (en)	1992-04-01	1997-06-17	The University Of Toledo	4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof
US5486526A (en) *	1992-04-01	1996-01-23	The University Of Toledo	Histamine H3 -receptor antagonists and therapeutic uses thereof
CA2154467A1 (en)	1993-01-25	1994-08-04	Kazuhiko Yanai	Imidazole-series compound
JP3522790B2 (en)	1993-06-08	2004-04-26	花王株式会社	H3-receptor stimulant
AU7823894A (en)	1993-08-27	1995-03-21	Vrije Universiteit	New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor
GB9319534D0 (en) *	1993-09-22	1993-11-10	Boots Co Plc	Therapeutic agents
JPH09505298A (en)	1993-11-15	1997-05-27	シェーリングコーポレイション	Phenyl-alkyl imidazoles as H-lower 3-receptor antagonists
GB9411045D0 (en) *	1994-06-02	1994-07-20	Smithkline Beecham Plc	Compounds and use
FR2732017B1 (en)	1995-03-21	2000-09-22	Inst Nat Sante Rech Med	NOVEL IMIDAZOLE DERIVATIVES AND / OR HISTAMINE H3 RECEPTOR AGONISTS AND / OR AGONISTS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS
DE69619381T2 (en)	1995-05-30	2002-11-21	Gliatech, Inc.	1H-4 (5) SUBSTITUTED IMIDAZOLE DERIVATIVES
US5652258A (en)	1995-05-30	1997-07-29	Gliatech, Inc.	2-(4-imidazoyl) cyclopropyl derivatives
ES2184876T3 (en)	1995-06-07	2003-04-16	Gliatech Inc	IMIDAZOL DERIVATIVES REPLACED IN 1H-4 (5).
WO1997029092A1 (en)	1996-02-09	1997-08-14	James Black Foundation Limited	Histamine h3 receptor ligands
JP3925579B2 (en)	1998-02-03	2007-06-06	日本精工株式会社	Lubricant supply body, rolling bearing including the lubricant supply body, linear guide device, and ball screw device
EP0982300A3 (en) *	1998-07-29	2000-03-08	Societe Civile Bioprojet	Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
US6136559A (en) *	1998-10-07	2000-10-24	Ortho Pharmaceutical Corporation	DNA encoding as human histamine receptor of the H3 subtype
SK287673B6 (en)	1999-06-11	2011-05-06	Toyama Chemical Co., Ltd	N-alkoxyalkyl-N,N-dialkylamine derivatives, pharmaceutical composition containing them and the use of them
GB9924941D0 (en) *	1999-10-22	1999-12-22	Univ Manchester	Treatment of dyskinesia
US6620839B2 (en) *	2000-07-13	2003-09-16	Abbott Laboratories	1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
ES2260276T3 (en)	2000-08-08	2006-11-01	Ortho-Mcneil Pharmaceutical, Inc.	NON-IMIDAZOLIC ARYLOXIALQUILAMINS AS LEGANDS OF THE H3 RECEIVER.
WO2002013821A1 (en)	2000-08-17	2002-02-21	Gliatech, Inc.	Novel alicyclic imidazoles as h3 agents
US20040006120A1 (en) *	2000-08-21	2004-01-08	Yates Stephen L	Use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity
JP4653935B2 (en) *	2001-03-29	2011-03-16	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	Imidazolyl derivatives useful as ligands for histamine H3 receptors
AU2002228698A1 (en) *	2001-11-15	2003-06-10	Ortho-Mcneil Pharmaceutical, Inc.	Agonists of recombinant human histamine h3 receptor
ES2259728T3 (en)	2001-12-10	2006-10-16	Ortho-Mcneil Pharmaceutical, Inc.	PHENYLALKINS.
EP1556046A1 (en)	2002-10-23	2005-07-27	Janssen Pharmaceutica N.V.	Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
FR2856596B1 (en) *	2003-06-27	2007-04-27	Bioprojet Soc Civ	NOVEL PSYCHIATRIC DRUG ASSOCIATION AND THE USE OF AN INVERSE HISTAMINE H3 RECEPTOR ANTAGONIST OR AGONIST TO PREPARE A MEDICAMENT PREVENTING ADVERSE EFFECTS OF PSYCHOTROPES.
AU2004257025B9 (en) *	2003-06-27	2010-05-27	Msd K.K.	Heteroaryloxy nitrogenous saturated heterocyclic derivative
SE0302116D0 (en) *	2003-07-21	2003-07-21	Astrazeneca Ab	Novel compounds
ATE547404T1 (en)	2003-09-22	2012-03-15	Msd Kk	PIPERIDINE DERIVATIVES

2005
- 2005-04-01 EP EP05290727A patent/EP1707203A1/en not_active Withdrawn
2006
- 2006-03-29 AU AU2006228413A patent/AU2006228413C1/en not_active Expired
- 2006-03-30 JP JP2008503613A patent/JP5546761B2/en not_active Expired - Lifetime
- 2006-03-30 RS RS20130359 patent/RS52911B2/en unknown
- 2006-03-30 UA UAA200710712A patent/UA94902C2/en unknown
- 2006-03-30 SG SG200807447-8A patent/SG147415A1/en unknown
- 2006-03-30 EP EP06744466.1A patent/EP1863487B2/en not_active Expired - Lifetime
- 2006-03-30 ES ES06744466T patent/ES2426008T5/en not_active Expired - Lifetime
- 2006-03-30 EA EA200702135A patent/EA016007B1/en not_active IP Right Cessation
- 2006-03-30 SI SI200631636T patent/SI1863487T2/en unknown
- 2006-03-30 PL PL06744466T patent/PL1863487T5/en unknown
- 2006-03-30 NZ NZ561940A patent/NZ561940A/en unknown
- 2006-03-30 DK DK06744466.1T patent/DK1863487T4/en active
- 2006-03-30 MX MX2007012162A patent/MX2007012162A/en active IP Right Grant
- 2006-03-30 CN CN2006800157656A patent/CN101171009B/en not_active Expired - Lifetime
- 2006-03-30 CA CA2603656A patent/CA2603656C/en not_active Expired - Lifetime
- 2006-03-30 WO PCT/IB2006/000739 patent/WO2006103546A2/en not_active Ceased
- 2006-03-30 PT PT67444661T patent/PT1863487E/en unknown
- 2006-03-30 US US11/909,778 patent/US8486947B2/en active Active
- 2006-03-30 BR BRPI0612216-7A patent/BRPI0612216B1/en active IP Right Grant
- 2006-03-30 HR HRP20130748T patent/HRP20130748T4/en unknown
- 2006-03-30 KR KR1020077025126A patent/KR101308527B1/en not_active Expired - Lifetime
- 2006-03-30 ME MEP-2013-98A patent/ME01713B/en unknown
2007
- 2007-09-20 ZA ZA200708086A patent/ZA200708086B/en unknown
- 2007-09-26 TN TNP2007000365A patent/TNSN07365A1/en unknown
- 2007-09-27 MA MA30254A patent/MA29353B1/en unknown
- 2007-10-09 NO NO20075086A patent/NO343603B1/en unknown
2013
- 2013-08-14 CY CY20131100705T patent/CY1114636T1/en unknown
2014
- 2014-01-06 JP JP2014000383A patent/JP5955872B2/en not_active Expired - Lifetime
2016
- 2016-03-09 JP JP2016045424A patent/JP2016106142A/en active Pending

Also Published As

Publication number	Publication date
AU2006228413A1 (en)	2006-10-05
US8486947B2 (en)	2013-07-16
SI1863487T1 (en)	2013-09-30
JP2008534572A (en)	2008-08-28
CA2603656C (en)	2015-06-16
EP1707203A1 (en)	2006-10-04
JP2016106142A (en)	2016-06-16
CA2603656A1 (en)	2006-10-05
RS52911B2 (en)	2019-11-29
WO2006103546A2 (en)	2006-10-05
EP1863487B2 (en)	2019-07-17
ZA200708086B (en)	2008-10-29
EA200702135A1 (en)	2008-04-28
BRPI0612216B1 (en)	2022-04-19
AU2006228413B2 (en)	2011-09-15
MX2007012162A (en)	2007-11-22
HRP20130748T1 (en)	2013-10-11
JP2014062126A (en)	2014-04-10
JP5955872B2 (en)	2016-07-20
ES2426008T5 (en)	2020-03-20
EP1863487B1 (en)	2013-05-29
RS52911B (en)	2014-02-28
KR101308527B1 (en)	2013-09-17
NO343603B1 (en)	2019-04-08
BRPI0612216A2 (en)	2010-10-26
AU2006228413C1 (en)	2012-02-02
SG147415A1 (en)	2008-11-28
EA016007B1 (en)	2012-01-30
ES2426008T3 (en)	2013-10-18
DK1863487T3 (en)	2013-08-12
CN101171009A (en)	2008-04-30
JP5546761B2 (en)	2014-07-09
TNSN07365A1 (en)	2008-12-31
CY1114636T1 (en)	2016-10-05
US20090318433A1 (en)	2009-12-24
SI1863487T2 (en)	2019-11-29
PL1863487T3 (en)	2014-10-31
HRP20130748T4 (en)	2019-11-15
MA29353B1 (en)	2008-03-03
DK1863487T4 (en)	2019-10-14
WO2006103546A3 (en)	2007-03-01
EP1863487A2 (en)	2007-12-12
PL1863487T5 (en)	2021-08-09
CN101171009B (en)	2012-11-07
KR20080002904A (en)	2008-01-04
UA94902C2 (en)	2011-06-25
NZ561940A (en)	2010-06-25
PT1863487E (en)	2013-08-29
NO20075086L (en)	2007-12-27

Publication	Publication Date	Title
SI1863487T2 (en)	2019-11-29	Treatment of symptoms of parkinson's disease with non-imidazole alkylamines histamine h3-receptor ligands
PT2601972E (en)	2015-02-09	Non-lithotripsic kidney-stone therapy
GB0506835D0 (en)	2005-05-11	Therapeutic use of nefopam
EP1768656A4 (en)	2008-01-23	Treatment for ocular disease
GB2430002B (en)	2009-06-03	Well treatment
GB0516068D0 (en)	2005-09-14	Well treatment
DE602006000763D1 (en)	2008-05-08	pillow body
GB0507003D0 (en)	2005-05-11	Therapeutic
GB0501655D0 (en)	2005-03-02	Therapeutic use
GB0410101D0 (en)	2004-06-09	Parkinson's disease
GB0515703D0 (en)	2005-09-07	Therapeutic use of nefopam
ZA200709075B (en)	2008-10-29	Novel histamine H3-receptor ligands and their therapeutic applications
EP1863510A4 (en)	2008-04-02	Methods for treating parkinson's disease
SG126063A1 (en)	2006-10-30	Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
AU305259S (en)	2006-02-01	Upper body garment
AU305258S (en)	2006-02-01	Upper body garment
AU305257S (en)	2006-02-01	Upper body garment
AU305255S (en)	2006-02-01	Upper body garment
AU305254S (en)	2006-02-01	Upper body garment
AU302683S (en)	2005-08-10	Upper body garment
AU305256S (en)	2006-02-01	Upper body garment
UA11936S (en)	2006-04-17	WOMEN'S UNIFORM SUIT
GB0517025D0 (en)	2005-09-28	Sexual stimulator
GB0413584D0 (en)	2004-07-21	Well treatment
GB0518537D0 (en)	2005-10-19	Therapeutic use